Understanding KCNT1–Related Epilepsy and the Antisense Oligonucleotide (ASO) Treatment Approach
Accessible description of the infographic
The infographic illustrates how gain-of-function mutations in KCNT1 lead to excessive activity of the KNa1.1 potassium channel, resulting in neuronal hyperexcitability and seizures. It also explains how antisense oligonucleotides (ASOs) may help by reducing KCNT1 protein production, thereby lowering channel activity and decreasing seizure-related neuronal hyperexcitability.
This infographic explains the normal function of the KCNT1 gene, the impact of gain-of-function KCNT1 mutations, and the mechanism of action of a potential treatment using antisense oligonucleotides (ASOs).
1. Normal role of KCNT1
The first section shows a neuron alongside a diagram of a KNa1.1 (KCNT1) potassium channel embedded in a neuronal membrane.
Potassium ions (K⁺) pass through the channel, helping regulate the electrical activity of the neuron. A waveform beneath the channel illustrates stable electrical signaling.
Text in the infographic:
Under normal conditions, the KNa1.1 channel opens when the intracellular sodium concentration is high. Potassium effluxes from the cell, helping to restore the neuron’s electrical balance.
2. Gain-of-function mutation in KCNT1
The middle section illustrates a KCNT1 channel affected by a gain-of-function mutation. The channel is depicted as hyperactive, allowing excessive potassium ion flow.
Below the channel, a red waveform shows abnormal neuronal electrical activity.
Text in the infographic:
A gain-of-function mutation makes the KNa1.1 channel abnormally active: potassium effluxes excessively, disrupting communication between neurons and leading to neuronal hyperexcitability and seizures.
3. Therapeutic approach: antisense oligonucleotide (ASO)
The third section illustrates how an antisense oligonucleotide (ASO) targets KCNT1 messenger RNA (mRNA).
The ASO binds specifically to KCNT1 mRNA, triggering degradation of the targeted mRNA before it can be translated into protein. As a result, fewer KNa1.1 channels are produced.
A final diagram shows reduced production of KCNT1 channels and a return toward more balanced neuronal activity.
Text in the infographic:
ASOs specifically and complementarily bind to KCNT1 mRNA, leading to its degradation. Less KNa1.1 protein is produced, which reduces the number of hyperactive channels and normalizes neuronal excitability.